Objectives:
- Review the evidence supporting the link between the gut microbiota and its effect on anti-cancer treatment
- Discuss strategies to modulate the gut microbiome to optimize efficacy of immunotherapy
- Consider potential mechanism by which the gut microbiome regulates immune response
and
- Provide an overview of pH-negative MPNS in accelerated phase and blast phase
- Discuss molecular mechanisms behind the development of blast phase
- Discuss treatment options and assessment of response to treatment
Session date:
06/24/2019 - 12:00pm to 1:00pm CDT
Location:
UCMC
5841 South Maryland Avenue, MC2115
MC2115 HemOnc Conference Room E-215
Chicago, IL
60637
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Carolina Soto Chervin, MD, PhD and Anand A. Patel, MD